Back to top

SETTLEMENT AGREEMENT AND MUTUAL RELEASE

Settlement Agreement

SETTLEMENT AGREEMENT AND MUTUAL RELEASE | Document Parties: BAYWOOD INTERNATIONAL INC | Farmatek IC VE DIS TIC, LTD You are currently viewing:
This Settlement Agreement involves

BAYWOOD INTERNATIONAL INC | Farmatek IC VE DIS TIC, LTD

. RealDealDocs™ contains millions of easily searchable legal documents and clauses from top law firms. Search for free - click here.
Title: SETTLEMENT AGREEMENT AND MUTUAL RELEASE
Governing Law: California     Date: 8/19/2009
Industry: Personal and Household Prods.     Sector: Consumer/Non-Cyclical

SETTLEMENT AGREEMENT AND MUTUAL RELEASE, Parties: baywood international inc , farmatek ic ve dis tic  ltd
50 of the Top 250 law firms use our Products every day

EXHIBIT 10.45

SETTLEMENT AGREEMENT AND MUTUAL RELEASE

This Settlement Agreement and General Release (hereinafter “Agreement”) is made this ___ day of May 2009 between the Farmatek IC VE DIS TIC, LTD. STI (“Farmatek”) and Oskiyan Hamdemir, on the one hand, and Baywood International, Inc. (“Baywood”) and Nutritional Specialties, Inc. (“NSI”), on the other hand.

RECITALS

A.

 On or about April 3, 2006, NSI and Farmatek executed an Exclusive Distribution Contract under which Farmatek agreed to serve as the exclusive distributor of NSI’s products in the territory of Turkey.

B.

By letter dated August 13, 2007, NSI gave Farmatek thirty days written notice of its decision to cancel the Exclusive Distribution Contract.

C.

On or about December 28, 2007 filed an action for breach of contract, breach of the implied covenant of good faith and fair dealing, unjust enrichment, and unfair business practices in Orange County Superior Court entitled, Farmatek IC VE DIS TIC, LTD. STI. V. Nutritional Specialties, Inc. dba Lifetime, Baywood International, Inc., and Does 1 through 25, inclusive , Case No. 00100814 (the “Action”).

D.

In or about October, 2007, Farmatek’s president, Oskiyan Hamdemir, applied for and obtained trademarks for the names of some of the private label products NSI produced exclusively for Farmatek, including products that Farmatek distributed and sold in Turkey under the parties’ Exclusive Distribution Contract.

E.

On or about October 15, 2008, Farmatek sent a warning letter to NSI, demanding that NSI cease selling and marketing the following products which Farmatek claimed it possessed registered trademarks: Alphadell, Alphamax, Argimax, Carvital, CLA Max, Genesis, Glucosol, HareCare, JSF, Multifem, MultiMen, Promax, Regulx, and Water X (collectively, “the Trademark Names”).

F.

The parties wish to resolve all possible disputes between them relating to the Action and the Trademark Names, whether known or unknown, and to provide for a general release of all such claims except as otherwise provided herein.

TERMS OF AGREEMENT

In consideration of the mutual covenants and promise herein contained, and for good and valuable consideration, the receipt and sufficiency of which are herby acknowledged, it is agreed:

1.

Payment .  For the execution of this Agreement by the Parties, Baywood and NSI shall pay to Farmatek the total sum of $250,000.  This amount shall be paid in 12 months pursuant to the following schedule:

 

1

 


a.

payment of $50,000 within 10 days of the execution of this Agreement;

b.

payment of $75,000 by September 15, 2009;

c.

payment of $75,000 by December 15, 2009; and

d.

a final payment of $50,000 by March 15, 2010.

As an incentive to provide early payment, Baywood and NSI’s total obligation under this paragraph will be reduced by Ten Thousand Dollars ($10,000) if Baywood and NSI make all the required payments by September 30, 2009.  All payments are to be made by international electronic wire transfer payable to Farmatek and sent to:

Bank: Turkiye Is Bankasi

Branch #: 1228

Account #: 52176

IBAN: TR62 0006 4000 0021 2280 0521 76

SWIFT: ISBKTRIS

2.

Impact of Nonpayment .  Except as provided in Paragraph 3, should Baywood and NSI fail to pay the amounts set forth in Paragraph 1 of this Agreement, and if not paid in full within fifteen (15) business days of a written demand by Farmatek, Farmatek may, in addition to its other remedies, upon written notice to Baywood and NSI, file the Stipulated Judgment attached as Exhibit A.

3.

Marketing and Sale of Products under the Trademarked Names .  Baywood and NSI represent and warrant it no longer manufactures products under the Trademarked Names for distribution in Turkey and agree that they will not do so in the future, except as otherwise provided in this Agreement.  Farmatek and Mr. Hamdemir acknowledge and agree that Baywood, NSI, and its current Turkish distributor may advertise, market, distribute, and sell in Turkey any products under the Trademarked Names that Baywood, NSI, or their Turkish distributor currently have in inventory or which are currently held by an Turkish pharmacy but only until August 30, 2009.

After August 30, 2009, Baywood, NSI and its current Turkish distributor will and shall stop any, every and all advertising, marketing, distribution and sale in Turkey of all products under the Trademarked Names.  This Agreement applies solely to the Trademarked Names and no other names.

Except in the event that Baywood, NSI, its/their Related Persons, or their Turkish distributor breaches the terms of this agreement with respect to payments or the Trademarked Names, Farmatek, Mr. Hamdemir, and any Related Persons agree that they will not take action against Baywood, NSI, their Turkish distributor to enforce any rights Farmatek or Mr. Hamdemir possesses with respect to the Trademarked Names and will not initiate, threaten to initiate or cause to be initiated either civil or criminal proceedings against Baywood, NSI or their Turkish distributor in connection with their past or permitted future manufacture, marketing, advertising, distribution, or sale of products under the Trademarked Names.

 

2

 


Except in the event that Baywood, NSI its/their Related Persons, or their Turkish distributor breaches the terms of this agreement with respect to payments or the Trademarked Names, Farmatek, Mr. Hamdemir, and any Related Persons agree that they will not initiate, threaten to initiate or cause to be initiated any action against any Turkish pharmacy or entity possessing, advertising, offering for sale and/or selling any products under the Trademarked Names.  In the event that Farmatek or Mr. Hamdemir violates the terms of this Paragraph, Baywood and/or NSI will have no obligation to make any further payments to Faramatek under Paragraph 1 of this Agreement and may seek damages against Faramtek and/or Mr. Hamdemir arising out of any violation of this paragraph.

 

If any Trademarked Names become invalidated, expires, non-renewed or otherwise loses trademark protection in Turkey such that third-parties become free to use the Trademarked Name then Baywood, NSI and their Related Parties shall be likewise free to use the Trademarked Names, without penalty or restriction.  Baywood, NSI and their Related Parties, however warrant and agree that they or their Turkish distributor will not initiate, participate, threaten to initiate or cause to be initiated any action, petition or proceedi


 
SITE SEARCH

AGREEMENTS / CONTRACTS

Document Title:

Entire Document: (optional)

Governing Law:(optional)


Try our advanced search >>
 

CLAUSES

Search Contract Clauses >>

Browse Contract Clause Library>>

Get Email Updates
Email:
This is only a partial view of this document. We have millions of legal documents and clauses drafted by top law firms. learn more search for free browse for free learn more